Rivaroxaban Dosing and Administration for Non-Valvular Atrial Fibrillation

Dosing Recommendations

The European Society of Cardiology recommends rivaroxaban 20 mg once daily with the evening meal for patients with non-valvular atrial fibrillation and normal renal function, and 15 mg once daily with the evening meal for patients with moderate renal impairment (CrCl 15-50 mL/min) 1, 2
Rivaroxaban is not recommended for patients with severe renal impairment (CrCl <15 mL/min) 1, 2

Taking rivaroxaban with the evening meal is essential to ensure adequate absorption, as recommended by the American College of Cardiology 3
Regular assessment of renal function is recommended after initiation of rivaroxaban, at least annually in patients with normal renal function and 2-3 times per year in those with moderate renal impairment, as suggested by the European Heart Journal 1

For patients with high bleeding risk (HAS-BLED score ≥3), the 15 mg once daily dose may be considered even with normal renal function, according to the European Heart Journal 1, 4
Assessment of bleeding risk is recommended before prescribing rivaroxaban, as advised by the European Heart Journal 1
There is no specific antidote to immediately reverse rivaroxaban's anticoagulant effect in case of hemorrhage, as noted by the American Family Physician 2, 5

Rivaroxaban is recommended for patients with non-valvular AF who have at least moderate risk of stroke (CHA₂DS₂-VASc score ≥2), as recommended by the European Heart Journal 1
It should not be used in patients with prosthetic heart valves, hemodynamically significant valve disease, or advanced liver disease, as advised by the American Family Physician 2, 5